Russell Frank Company’s Impax Laboratories, Inc. IPXL Stock Holding History

Russell Frank Company’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.63M	Buy	50,844 +11,922	+31%	+$419K	﹤0.01%	1956
2015 Q4	$1.7M	Sell	38,922 -9,036	-19%	-$361K	﹤0.01%	1931
2015 Q3	$1.69M	Sell	47,958 -12,685	-21%	-$572K	﹤0.01%	1947
2015 Q2	$2.79M	Sell	60,643 -3,858	-6%	-$183K	﹤0.01%	1793
2015 Q1	$3.02M	Sell	64,501 -21,185	-25%	-$843K	0.01%	1535
2014 Q4	$2.74M	Sell	85,686 -152,708	-64%	-$4.47M	﹤0.01%	1603
2014 Q3	$5.65M	Buy	238,394 +83,788	+54%	+$2.15M	0.01%	1205
2014 Q2	$3.62M	Buy	154,606 +131,182	+560%	+$3.54M	0.01%	1470
2014 Q1	$619K	Sell	23,424 -20,400	-47%	-$510K	﹤0.01%	2298
2013 Q4	$1.03M	Buy	43,824 +20,809	+90%	+$464K	﹤0.01%	2056
2013 Q3	$472K	Buy	23,015 +19,675	+589%	+$406K	﹤0.01%	2505
2013 Q2	$67K	Buy	+3,340	New	+$59.3K	﹤0.01%	2826

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's IPXL Position: Q1 2016 in Review

Russell Frank Company increased its Impax Laboratories, Inc. (IPXL) stake by 31% in Q1 2016, buying an estimated $419K and bringing the position to 50,844 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Russell Frank Company first reported a position in IPXL in Q2 2013 and has held it in 12 quarters since. The position peaked at $5.65M in Q3 2014. 194 funds tracked by Wall St. Rank hold IPXL as of Q1 2016.

Russell Frank Company held 50,844 shares of Impax Laboratories, Inc. worth $1.63M as of Q1 2016.
Russell Frank Company bought 11,922 Impax Laboratories, Inc. shares in Q1 2016, an estimated $419K.
Impax Laboratories, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1956 holding.
Russell Frank Company first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Impax Laboratories, Inc. position peaked at $5.65M in Q3 2014.
194 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.